Archives

by in
Entry Author Date Location
Brushing Off Clinical Setback, Cerulean Tees Up $75M IPO 03/10/14 Boston
UCSD “Entrepreneur Challenge” Awards Top Honors to DevaNano, GrollTex 06/11/13 San Diego
East Coast Life Sciences Roundup: Optimer, Bind, Pfizer, and More 04/05/13 Boston
Bind Therapeutics Reels Pfizer into Nanomedicine Partnership 04/03/13 Boston
BIND CEO Says Amgen Deal Marks Nanomedicine Turning Point 01/09/13 Boston
Blend Therapeutics Raises $16 Million to Fund Cancer Drug Development 12/18/12 Boston
East Coast Life Sciences Roundup: Selecta, Rib-X, Cambridge, & More 11/30/12 Boston
Selecta in Development Deal with Sanofi Worth up to $900 Million 11/28/12 Boston
Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases 03/19/12 Boston
Potential Treatment for Degenerative Eye Diseases Developed at Wayne State 12/22/11 Detroit
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News 07/29/11 Boston
Cerulean Shows Progress in Cancer, Tests Nano-Drug Platform in RNAi 07/27/11 Boston
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News 07/02/10 Boston
Former J&J Group Chairman’s Firm Backs BIND Biosciences in $12.4M Round 06/29/10 Boston
Selecta Scores $15M, Fate Expands into Canada, Xconomy Launches Health IT Channel, & More Boston-Area Life Sciences News 04/09/10 Boston
New Life Sciences Startup Shows UCSD Technology Can Boost Immune Response to Cancer in Mice 10/14/09 San Diego
Daily TIPs: Tech Czar, Nanoparticles, Hackers, & More 06/27/08 National
Page 1 of 1